BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance

21 11月 2022 17:15:01 条件 Nasdaq GlobeNewswire

Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022

16 11月 2022 17:15:00 条件 Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance

08 11月 2022 07:30:01 条件 Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022

31 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago   

12 10月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Bioventus to Present at the Morgan Stanley Global Healthcare Conference

30 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance

11 8月 2022 07:00:03 条件 Nasdaq GlobeNewswire

Bioventus Receives FDA 510(k) Clearance for SonaStar Elite  

03 8月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

26 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Bioventus Completes CartiHeal Acquisition

12 7月 2022 08:30:00 条件 Nasdaq GlobeNewswire

Bioventus Amends CartiHeal Acquisition Structure

21 6月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

10 5月 2022 07:00:04 条件 Nasdaq GlobeNewswire

Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

03 5月 2022 17:47:17 条件 Nasdaq GlobeNewswire

Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis

02 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

26 4月 2022 09:05:09 条件 Nasdaq GlobeNewswire

Bioventus Announces $415 Million Offering of Senior Notes

26 4月 2022 08:38:49 条件 Nasdaq GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

25 4月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

08 4月 2022 09:15:08 条件 Nasdaq GlobeNewswire

Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton

05 4月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Bioventus Exercises Call Option to Acquire CartiHeal

04 4月 2022 07:00:00 条件 Nasdaq GlobeNewswire